Tumor Necrosis Factor-α Mediates Photoreceptor Death in a Rodent Model of Retinal Detachment

作者: Toru Nakazawa , Maki Kayama , Morin Ryu , Hiroshi Kunikata , Ryou Watanabe

DOI: 10.1167/IOVS.10-6509

关键词:

摘要: Photoreceptors are vulnerable in several retinal disorders, including macular degeneration,1 detachment (RD),2–4 diabetic retinopathy,5 retinopathy of prematurity,6 and retinitis pigmentosa.7 In these pathologic conditions, photoreceptors undergo apoptosis.2,5–7 Therefore, new insights about the mechanisms that underlie photoreceptor degeneration ocular diseases would be clinical interest could lead to neuroprotective treatments. Previously, we used rodent model RD clarify mechanism RD-induced degeneration. We found apoptosis went through a caspase-dependent8,9 or caspase-independent pathway.10 Furthermore, monocytes recruited upregulation monocyte chemoattractant protein (MCP)-1 Muller glial cells play neurodestructive role degeneration.11,12 Tumor necrosis factor (TNF)-α is synthesized, mainly monocytes, as 26-kDa precursor13 cleaved proteolytically secreted 17-kDa protein.14 TNFα acts via either low-affinity TNF receptor (TNFR1) high-affinity (TNFR2).15 upregulated neurodegenerative disorders multiple sclerosis, Parkinson's disease, Alzheimer's disease suppression has demonstrated therapeutic effects.16 ophthalmic vitreous samples from patients with contain significantly higher levels than other such hole idiopathic premacular fibrosis.17,18 However, elevated on remains unclear. Recently, TNFα-suppressing monoclonal antibodies infliximab have been successfully treat inflammatory Behcet's disease,19 diffuse subretinal fibrosis (DSF) syndrome,20 posterior scleritis,21 vascular tumors,22 neovascular age-related degeneration.23 Thus, if plays degeneration, anti-TNFα treatment may good candidate for diseases. this study, induced mice deficient TNF, TNFR1, TNFR2 investigated pathway apoptosis.

参考文章(42)
Dziewulska D, Mossakowski Mj, Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clinical Neuropathology. ,vol. 22, pp. 35- 40 ,(2003)
Durrani K, Ahmed M, Foster Cs, Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations. Comprehensive ophthalmology update. ,vol. 8, pp. 225- ,(2007)
Stoll Guido, Jander Sebastian, Michael Schroeter, Detrimental and Beneficial Effects of Injury-Induced Inflammation and Cytokine Expression in the Nervous System Advances in Experimental Medicine and Biology. ,vol. 513, pp. 87- 113 ,(2003) , 10.1007/978-1-4615-0123-7_3
Joel M. Dopp, Theodore A. Sarafian, Francesca M. Spinella, Michelle A. Kahn, Hungyi Shau, Jean de Vellis, Expression of the p75 TNF receptor is linked to TNF-induced NFkappaB translocation and oxyradical neutralization in glial cells. Neurochemical Research. ,vol. 27, pp. 1535- 1542 ,(2002) , 10.1023/A:1021608724117
Heather A. Arnett, Jeff Mason, Mike Marino, Kinuko Suzuki, Glenn K. Matsushima, Jenny P.-Y. Ting, TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neuroscience. ,vol. 4, pp. 1116- 1122 ,(2001) , 10.1038/NN738
DG Charteris, RD Hollifield, AH Chignell, GA Limb, L Webster, Soluble TNF receptors in vitreoretinal proliferative disease. Investigative Ophthalmology & Visual Science. ,vol. 42, pp. 1586- 1591 ,(2001)
N. A. C. H. Brabers, H. S. L. M. Nottet, Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. European Journal of Clinical Investigation. ,vol. 36, pp. 447- 458 ,(2006) , 10.1111/J.1365-2362.2006.01657.X
Bennett D. Elzey, Thomas S. Griffith, John M. Herndon, Ramon Barreiro, Jurg Tschopp, Thomas A. Ferguson, Regulation of Fas Ligand-Induced Apoptosis by TNF Journal of Immunology. ,vol. 167, pp. 3049- 3056 ,(2001) , 10.4049/JIMMUNOL.167.6.3049
ML Moss, S-LC Jin, JD Becherer, DM Bickett, W Burkhart, W-J Chen, D Hassler, MT Leesnitzer, G McGeehan, M Milla, M Moyer, W Rocque, T Seaton, F Schoenen, J Warner, D Willard, None, Structural features and biochemical properties of TNF-α converting enzyme (TACE) Journal of Neuroimmunology. ,vol. 72, pp. 127- 129 ,(1997) , 10.1016/S0165-5728(96)00180-4